GNE-207
Modify Date: 2025-08-27 09:38:56
GNE-207 structure
|
Common Name | GNE-207 | ||
|---|---|---|---|---|
| CAS Number | 2158266-58-9 | Molecular Weight | 510.59 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C29H30N6O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of GNE-207GNE-207 is a potent, selective and orally bioavailable inhibitor of the bromodomain of CBP, with an IC50 of 1 nM, a selectively index of >2500-fold against BRD4 (1) (IC50, 3.1 μM)[1]. GNE-207 shows excellent CBP potency, with an EC50 of 18 nM for MYC expression in MV-4-11 cells[1]. |
| Name | GNE-207 |
|---|
| Description | GNE-207 is a potent, selective and orally bioavailable inhibitor of the bromodomain of CBP, with an IC50 of 1 nM, a selectively index of >2500-fold against BRD4 (1) (IC50, 3.1 μM)[1]. GNE-207 shows excellent CBP potency, with an EC50 of 18 nM for MYC expression in MV-4-11 cells[1]. |
|---|---|
| Related Catalog | |
| Target |
CBP:1 nM (IC50) BRD4(1):3.1 μM (IC50) |
| In Vitro | GNE-207 is a potent, selective and orally bioavailable inhibitor of the bromodomain of CBP, with an IC50 of 1 nM, a selectively index of >2500-fold against BRD4 (1) (IC50, 3.1 μM)[1]. GNE-207 shows excellent CBP potency, with an EC50 of 18 nM for MYC expression in MV-4-11 cells[1]. |
| In Vivo | GNE-207 (5 mg/kg) shows moderate clearance in PK, with acceptable oral bioavailability[1]. |
| References |
| Molecular Formula | C29H30N6O3 |
|---|---|
| Molecular Weight | 510.59 |